Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Neyts

Showing results (31-40 of 587) with videos related to

Pageof 59
Sort By:
Current Opinion in Virology|April 9, 2013
Intervention strategies for emerging viruses: use of antiviralsYannick Debing, Dirk Jochmans, Johan Neyts
Current Opinion in Virology|April 18, 2017
Chikungunya virus infections: time to act, time to treatRana Abdelnabi, Johan Neyts, Leen Delang
Medicinal Research Reviews|June 1, 2013
Molecular biology and inhibitors of hepatitis A virusYannick Debing, Johan Neyts, Hendrik Jan Thibaut
Novartis Foundation Symposium|February 27, 2007
Mouse and hamster models for the study of therapy against flavivirus infectionsNathalie Charlier, Erik De Clercq, Johan Neyts
Biochemical and Biophysical Research Communications|September 3, 2003
Selective inhibition of hepatitis B virus replication by RNA interferenceChunxiao Ying, Erik De Clercq, Johan Neyts
Gastroenterology|November 28, 2017
New Models to Study Hepatitis E Virus Replication and Particular Characteristics of Infection: The Needle Hides in the Hay StackYannick Debing, Michael A Schmid, Johan Neyts
Biochemical Pharmacology|June 4, 2014
Norovirus: targets and tools in antiviral drug discoveryJoana Rocha-Pereira, Johan Neyts, Dirk Jochmans
Antimicrobial Agents and Chemotherapy|August 17, 2002
Effect of 5-iodo-2'-deoxyuridine on vaccinia virus (orthopoxvirus) infections in miceJohan Neyts, Erik Verbeken, Erik De Clercq
Molecular Pharmacology|January 20, 2006
The anti-yellow fever virus activity of ribavirin is independent of error-prone replicationPieter Leyssen, Erik De Clercq, Johan Neyts
Antiviral Research|March 4, 2008
Molecular strategies to inhibit the replication of RNA virusesPieter Leyssen, Erik De Clercq, Johan Neyts
Pageof 59

Showing results (31-40 of 587) with videos related to

Sort By:
Pageof 59
Current Opinion in Virology|April 9, 2013
Intervention strategies for emerging viruses: use of antiviralsYannick Debing, Dirk Jochmans, Johan Neyts
Current Opinion in Virology|April 18, 2017
Chikungunya virus infections: time to act, time to treatRana Abdelnabi, Johan Neyts, Leen Delang
Medicinal Research Reviews|June 1, 2013
Molecular biology and inhibitors of hepatitis A virusYannick Debing, Johan Neyts, Hendrik Jan Thibaut
Novartis Foundation Symposium|February 27, 2007
Mouse and hamster models for the study of therapy against flavivirus infectionsNathalie Charlier, Erik De Clercq, Johan Neyts
Biochemical and Biophysical Research Communications|September 3, 2003
Selective inhibition of hepatitis B virus replication by RNA interferenceChunxiao Ying, Erik De Clercq, Johan Neyts
Gastroenterology|November 28, 2017
New Models to Study Hepatitis E Virus Replication and Particular Characteristics of Infection: The Needle Hides in the Hay StackYannick Debing, Michael A Schmid, Johan Neyts
Biochemical Pharmacology|June 4, 2014
Norovirus: targets and tools in antiviral drug discoveryJoana Rocha-Pereira, Johan Neyts, Dirk Jochmans
Antimicrobial Agents and Chemotherapy|August 17, 2002
Effect of 5-iodo-2'-deoxyuridine on vaccinia virus (orthopoxvirus) infections in miceJohan Neyts, Erik Verbeken, Erik De Clercq
Molecular Pharmacology|January 20, 2006
The anti-yellow fever virus activity of ribavirin is independent of error-prone replicationPieter Leyssen, Erik De Clercq, Johan Neyts
Antiviral Research|March 4, 2008
Molecular strategies to inhibit the replication of RNA virusesPieter Leyssen, Erik De Clercq, Johan Neyts
Pageof 59